Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. MU
6. META
7. ACN
8. FDX
9. NVDA
10. BLZE

Go back to Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Enliven Therapeutics, Inc (ELVN) Tops Q4 EPS by 6c

March 13, 2025 4:12 PM EDT

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

... More